Navigate Fool.com
Will PCYC beat
the market?


Community Rating: 2 Stars: Unattractive

95.55 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.20
Previous Close $95.55
Daily Range $93.42 - $96.23
52-Week Range $82.51 - $154.89
Market Cap $7.2B
P/E Ratio 51.80
Dividend (Yield) $0.00 (0.0%)
Volume 553,799
Average Daily Volume 1,010,818
Current FY EPS $0.30

How do you think PCYC
will perform against the market?

Top PCYC Bull/Bear Pitches


zzlangerhans (< 20)
Submitted April 2, 2014

I think it's safe to admit that the violence of the recent biopharma downturn caught zzporte somewhat unprepared. We were a little overextended, especially on Tekmira, and relatively low on cash. Whil … More

0 Replies Reply Report this Post

50daymovingshort (< 20)
Submitted April 10, 2013

This pick was made because its below the 50day moving average as of April 10th. The whole list I perused through below 50dmva for 4/10/13 were; AMZN,SIRI,PRAN,PCYC,CNQR,PCLN,CRM,LULU,CVLT,NFLX,ULTI,CT … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

Is Pharmacyclics the Next Celgene?

Pharmacyclics and Johnson & Johnson have a potential blockbuster in Imbruvica that may put Pharmacyclics on a similar path as Celgene.

4 Top Biotechs Expected to Beat Earnings Expectations

3 Stocks Crushed by the Market This Week

To every yin there's a yang. These 3 losing stocks definitely "yanged" to the overall market's yin this week.

Johnson & Johnson Scores a Solid Hit With Imbruvica

J&J knows how to make great deals come together, but will it pay off for investors?

Why TG Therapeutics Inc. Shares Temporarily Plunged

TG Therapeutics shares nosedive following intriguing clinical data, but quickly rebound. Find out what has investors so confused today.

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

ASCO: Cancer Drug Showdown

Ariad, Pharmacyclics, and Johnson & Johnson present impressive data. Clovis battles with AstraZeneca.

1 Biotech Steamrolling the Competition

This biotech is on a roll -- and new data help keep it going.

Analyst Cancer and Biotech Stock Picks From ASCO

3 Stocks Crushed by the Market Last Week

Down by double digits in just a few days. Why these 3 health-care stocks were the most horrendous performers this week.

See More PCYC News...






A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks